首页> 美国卫生研究院文献>Clinical and Molecular Hepatology >Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results

【2h】

Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results

机译：晚期肝细胞癌合并动静脉或动静脉分流的患者的肝内动脉输注联合瘤内注射化疗联合治疗：初步结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsCombination treatment consisting of hepatic arterial infusion chemotherapy with epirubicin and cisplatin (HAIC-EC) and systemic infusion of low-dose 5-fluorouracil (5-FU) are sometimes effective against advanced hepatocellular carcinoma (HCC). However, there is no effective treatment for advanced HCCs with arterioportal shunts (APS) or arteriovenous shunts (AVS).

机译：背景/目的由肝动脉灌注化疗加表柔比星和顺铂组成的联合治疗（HAIC-EC）和小剂量5-氟尿嘧啶（5-FU）的全身输注有时对晚期肝细胞癌（HCC）有效。然而，对于动静脉分流器（APS）或动静脉分流器（AVS）的晚期HCC，尚无有效的治疗方法。

著录项

期刊名称 Clinical and Molecular Hepatology
作者
Ja Seon Kim; Young Min Park; Nha Young Kim; Han Kyeol Yun; Ki Jong Lee; Bo Hyun Kim; Sang Jong Park; Jae Woo Yeon; Guhung Jung;
展开▼
作者单位

展开▼
年(卷),期 2011(17),2
年度 2011
页码 120–129
总页数 10
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Hepatocellular carcinoma Arterioportal shunt Intratumoral injection chemotherapy Interferon-gamma;

机译：肝细胞癌;动静脉分流;瘤内注射化疗;γ干扰素;

相似文献

外文文献
中文文献
专利

1. 经动脉化疗栓塞术和重组人5型腺病毒H101联合治疗延长中晚期肝细胞癌患者总生存期:预后列线图研究 [J] . Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin 癌症（英文版） . 2018,第003期
2. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study [J] . Yasui Daisuke, Murata Satoru, Ueda Tatsuo, Acta Radiologica . 2018,第3期

机译：晚期肝细胞癌的新型治疗策略：常规经管动脉化疗栓塞和改良方法与动脉静脉门静脉闭塞的组合：初步研究
3. Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma [J] . Naoto Kawabe, Senju Hashimoto, Takuji Nakano, JGH OPEN . 2021,第6期

机译：具有顺铂的经变性动脉输注化疗与经导管动脉化疗组合的组合降低了不可切除的肝细胞癌的肝内静脉内复发
4. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma [J] . Ming-Sheng Huang, Qu Lin, Zai-Bo Jiang, World Journal of Gastroenterology . 2004,第6期

机译：动脉内输送的乙醇和明胶泡沫对肝细胞癌患者重度门静脉分流的长期疗效比较
5. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
6. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
7. Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma [O] . Naoto Kawabe, Senju Hashimoto, Takuji Nakano, 2021

机译：具有顺铂的经变性动脉灌注化疗与经截面动脉化疗栓塞组合降低了不可切除的肝细胞癌的肝内远程复发
8. Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results [O] . Kim, Ja Seon, Park, Young Min, Kim, Nha Young, 2011

机译：晚期肝细胞癌合并动静脉或动静脉分流的患者的肝内动脉输注联合瘤内注射化疗联合治疗：初步结果

Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results

摘要

著录项

相似文献

相关主题

期刊订阅